165 related articles for article (PubMed ID: 11197083)
21. Prostaglandin moieties that determine receptor binding specificity in the bovine corpus luteum.
Anderson LE; Schultz MK; Wiltbank MC
J Reprod Fertil; 1999 May; 116(1):133-41. PubMed ID: 10505064
[TBL] [Abstract][Full Text] [Related]
22. Evidence for human thromboxane receptor heterogeneity using a novel series of 9,11-cyclic carbonate derivatives of prostaglandin F2 alpha.
Krauss AH; Woodward DF; Gibson LL; Protzman CE; Williams LS; Burk RM; Gac TS; Roof MB; Abbas F; Marshall K; Senior J
Br J Pharmacol; 1996 Mar; 117(6):1171-80. PubMed ID: 8882612
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
Palea S; Toson G; Pietra C; Trist DG; Artibani W; Romano O; Corsi M
Br J Pharmacol; 1998 Jul; 124(5):865-72. PubMed ID: 9692770
[TBL] [Abstract][Full Text] [Related]
24. The mechanism of inhibition of 3T3-L1 preadipocyte differentiation by prostaglandin F2alpha.
Miller CW; Casimir DA; Ntambi JM
Endocrinology; 1996 Dec; 137(12):5641-50. PubMed ID: 8940395
[TBL] [Abstract][Full Text] [Related]
25. In vitro pharmacological characterization of the prostanoid receptor population in the non-pregnant porcine myometrium.
Cao J; Shayibuzhati M; Tajima T; Kitazawa T; Taneike T
Eur J Pharmacol; 2002 May; 442(1-2):115-23. PubMed ID: 12020689
[TBL] [Abstract][Full Text] [Related]
26. Preclinical pharmacology of AL-12182, a new ocular hypotensive 11-oxa prostaglandin analog.
Sharif NA; McLaughlin MA; Kelly CR; Xu S; Crider JY; Williams GW; Parker JL
J Ocul Pharmacol Ther; 2006 Oct; 22(5):291-309. PubMed ID: 17076623
[TBL] [Abstract][Full Text] [Related]
27. Identification of an antagonist that selectively blocks the activity of prostamides (prostaglandin-ethanolamides) in the feline iris.
Woodward DF; Krauss AH; Wang JW; Protzman CE; Nieves AL; Liang Y; Donde Y; Burk RM; Landsverk K; Struble C
Br J Pharmacol; 2007 Feb; 150(3):342-52. PubMed ID: 17179945
[TBL] [Abstract][Full Text] [Related]
28. Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques.
Sharif NA; Davis TL
J Pharm Pharmacol; 2002 Apr; 54(4):539-47. PubMed ID: 11999132
[TBL] [Abstract][Full Text] [Related]
29. Prostanoid receptors EP2, EP4, and FP are regulated by estradiol in bovine oviductal smooth muscle.
Huang N; Liu B; Dong Z; Mao W; Zhang N; Li C; Cao J
Prostaglandins Other Lipid Mediat; 2015 Sep; 121(Pt B):170-5. PubMed ID: 26319698
[TBL] [Abstract][Full Text] [Related]
30. Regulation of human penile smooth muscle tone by prostanoid receptors.
Angulo J; Cuevas P; La Fuente JM; Pomerol JM; Ruiz-Castañé E; Puigvert A; Gabancho S; Fernández A; Ney P; Sáenz De Tejada I
Br J Pharmacol; 2002 May; 136(1):23-30. PubMed ID: 11976264
[TBL] [Abstract][Full Text] [Related]
31. Identification of a single (FP) receptor associated with prostanoid-induced Ca2+ signals in Swiss 3T3 cells.
Woodward DF; Lawrence RA
Biochem Pharmacol; 1994 Apr; 47(9):1567-74. PubMed ID: 8185669
[TBL] [Abstract][Full Text] [Related]
32. THG113: a novel selective FP antagonist that delays preterm labor.
Peri KG; Quiniou C; Hou X; Abran D; Varma DR; Lubell WD; Chemtob S
Semin Perinatol; 2002 Dec; 26(6):389-97. PubMed ID: 12537309
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
34. Identification of prostanoid receptors in rabbit non-pigmented ciliary epithelial cells.
Bhattacherjee P; Jacobs N; Coca-Prados M; Paterson C
Exp Eye Res; 1996 May; 62(5):491-8. PubMed ID: 8759517
[TBL] [Abstract][Full Text] [Related]
35. Bovine iris-sphincter muscle lacks FP receptor binding sites.
Bhattacherjee P; Williams BS; Mukhopadhyay P; Paterson CA
Ocul Immunol Inflamm; 1999 Mar; 7(1):39-50. PubMed ID: 10410874
[TBL] [Abstract][Full Text] [Related]
36. In vitro characterization of prostanoid FP-, DP-, IP- and TP-receptors on the non-pregnant human myometrium.
Senior J; Sangha R; Baxter GS; Marshall K; Clayton JK
Br J Pharmacol; 1992 Sep; 107(1):215-21. PubMed ID: 1422574
[TBL] [Abstract][Full Text] [Related]
37. Cat iris sphincter smooth-muscle contraction: comparison of FP-class prostaglandin analog agonist activities.
Sharif NA; Kaddour-Djebbar I; Abdel-Latif AA
J Ocul Pharmacol Ther; 2008 Apr; 24(2):152-63. PubMed ID: 18355130
[TBL] [Abstract][Full Text] [Related]
38. Radioligand binding analysis of receptor subtypes in two FP receptor preparations that exhibit different functional rank orders of potency in response to prostaglandins.
Woodward DF; Fairbairn CE; Krauss AH; Lawrence RA; Protzman CE
J Pharmacol Exp Ther; 1995 Apr; 273(1):285-7. PubMed ID: 7714778
[TBL] [Abstract][Full Text] [Related]
39. Comparative studies on prostanoid receptors in human non-pigmented ciliary epithelial and mouse fibroblast cell lines.
Liu L; Eta E; Bhattacherjee P; Paterson CA
Prostaglandins Leukot Essent Fatty Acids; 1996 Oct; 55(4):231-40. PubMed ID: 8951991
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E2 inhibits mast cell-dependent bronchoconstriction in human small airways through the E prostanoid subtype 2 receptor.
Säfholm J; Manson ML; Bood J; Delin I; Orre AC; Bergman P; Al-Ameri M; Dahlén SE; Adner M
J Allergy Clin Immunol; 2015 Nov; 136(5):1232-9.e1. PubMed ID: 25962903
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]